Clinical Trials

MNP2.0

Molecular Neuropathology 2.0

Brain and other Central Nervous System (CNS) Tumours

Status: Closed to Recruitment | NSW , QLD , SA , TAS , VIC , WA

There are a range of brain tumours that can occur in children. Correct diagnosis is essential to select the best treatment option, but it is not always easy for pathologists to accurately determine each tumour type. MNP2.0 offers molecular analysis of brain tumours to assist the traditional diagnostic techniques, and provides additional information regarding molecular classification, genetic changes and potential therapeutic targets. Samples of the brain tumour are shipped to Germany and the results provided to treating oncologists in Australia and New Zealand.

Disease Stage: Newly diagnosed

Patient Age Range: Up to 21 years

Trial Sponsors:

  • International: DFKZ (German Cancer Research Centre)
  • National: ANZCHOG

ANZCHOG acknowledges the valuable support of MNP2.0 by the RCD Foundation and Carrie's Beanies for Brain Cancer

logo-rcd-e1599805043641.jpg
CB4BC_Stacked_RGB-copy-e1553051856886.jpg

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.